Release Date: 06/08/14 09:19 Summary: Revised Investor Presentation - August 2014 Price Sensitive: No Download Document 2.72MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%